TCTR20240401009已完成3 期
EVOFLOXACIN PREVENTS FEBRILE NEUTROPENIA DURING CYTARABINE CONSOLIDATION (IDAC/HIDAC) IN ACUTE MYELOID LEUKEMIA
none0 个研究点目标入组 36 人开始时间: 2024年4月1日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 36
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 65 Years（—）
- 性别
- All
入选标准
- •Aged 18-65 years old
- •Newly diagnosed AML S/P IDAC/HIDAC From Jan 2021 to Dec 2023
- •Accept Informed consent
排除标准
- •Rate of hospital admission due to febrile neutropenia
- •Length of hospital stay due to febrile neutropenia
- •Culture-positive bacteremia rate
- •Composite outcome of septic shock rate and infectious-related mortality
- •Side effects of levofloxacin
- •Clostridium difficile-associated disease in 30 days after taking levofloxacin
- •Fluoroquinolone resistance organism
研究者
相似试验
招募中
2 期
Role of etifoxine, as an adjunctive treatment in patients diagnosed with medically resistant focal epilepsy with comorbid anxiety symptoms (The ETIFOXs)AllopregnanoloneEtifoxineFocal EpilepsyResistant epilepsyAnxietyTCTR20210925001Faculty Pharmaceutical Science Burapha University40
招募中
4 期
ENRICH-TAVISevere aortic stenosisD001024JPRN-jRCTs071180025Kenichi Tsujita100
招募中
3 期
The effectiveness of levofloxacin in prevention of febrile episodes in non-Hodgkin lymphoma patients receiving R-CHOPFebrile episode in non-Hodgkin lymphomaFebrile episodeLevofloxacinR-CHOPNon-Hodgkin lymphomaTCTR20230719005Ratchadapisek Research Funds72
已完成
2 期
Garenoxacin to Prevent Febrile Neutropenia in Chemotherapy for Lung Cancerung cancerJPRN-UMIN000014711Institute of Biomedical Research and Innovation30
已完成
不适用
Pentoxifylline and vitamin E treatment for prevention of radiation induced side effects in women with breast cancerCancerBreast cancerISRCTN39143623und University Hospital (Sweden)80